英恆科技(01760.HK)於科學園成立研發中心
英恆科技(01760.HK)宣布,於香港科學園成立研發中心,作為集團在大灣區的戰略部署,冀望能加速集團海外市場擴展,及建立國際化的人才團隊。
英恆科技聯席創辦人、主席及聯席行政總裁陸穎鳴表示,香港將成為集團在大灣區最大的營運基地,研發中心主要負責汽車智能化軟件、先進功率半導體應用、以及協作機械人解決方案,專注協助香港以及海外企業,加快拓展中國新能源汽車市場,同時也為進軍海外市場作好部署。
陸穎鳴表示,集團致力成為大灣區微電子、機械人和智能駕駛領域的關鍵合作夥伴,期望能成為加速新能源汽車、機械人和智能駕駛等前沿科技的研發與產業化的重要推手之一。(ca/u)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.